tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Sriharsha Pappu, 15 are a BUY (71.43%), 4 are a HOLD (19.05%), 2 are a SELL (9.52%).
Analyst Sriharsha Pappu, currently employed at HSBC, carries an average stock price target met ratio of 57.62% that have a potential upside of 18.94% achieved within 203 days.
Sriharsha Pappu’s has documented 43 price targets and ratings displayed on 7 stocks. The coverage is on the Basic Materials sector.
Most recent stock forecast was given on AMRS, Amyris at 13-May-2022.
Analyst best performing recommendations are on DNA (GINKGO BIOWORKS HOLDINGS).
The best stock recommendation documented was for DNA (GINKGO BIOWORKS HOLDINGS) at 9/21/2021. The price target of $14 was fulfilled within 28 days with a profit of $2.3 (19.66%) receiving and performance score of 7.02.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$0.65
$0.51 (364.29%)
$3.35
2 years 5 months 15 days ago
(18-May-2023)
2/2 (100%)
$0.06 (10.17%)
10
Buy
$1.25
$1.2 (2400.00%)
$19
2 years 5 months 24 days ago
(10-May-2023)
3/4 (75%)
$2.13 (47.39%)
21
Buy
$5
$4.86 (3471.43%)
$30
2 years 7 months 17 days ago
(16-Mar-2023)
7/10 (70%)
$3.68 (278.79%)
819
Hold
$2
$1.86 (1328.57%)
$2.5
2 years 9 months 30 days ago
(03-Jan-2023)
1/2 (50%)
$0.55 (37.93%)
2
Hold
2 years 11 months 24 days ago
(09-Nov-2022)
1/2 (50%)
$7.57 (43.43%)
391
What Year was the first public recommendation made by Sriharsha Pappu?
